Michael J. Evelegh

, PhD

Assistant Professor (Part-Time)
Pathology and Molecular Medicine

Executive Vice-President, Clinical and Regulatory Affairs,
PreMD, Inc.

McMaster University
3N11B Health Sciences Centre
905-525-9140 ext. 22805
evelm@mcmaster.ca

Education and Professional Standing

PhD, Immunology, McMaster University
BSc, Biology, Laurentian University

---

Interests

Research Interests

• Regulatory and clinical management of medical devices to obtain clearance from regulatory bodies.
• Development of novel technologies applicable to in vitro diagnostics

Academic Interests

Dr. Evelegh is currently involved teaching within the Faculty of Health Sciences as a tutorial leader for the Bachelor of Health Sciences Program course HTH SCI 4J03, Biochemical Immunology.

---

Selected Publications

• Chagpar A, Evelegh,M, Fritsche HA, Krisnamurthy S, Hunt KK, Kuerer HM. 2004. Prospective evaluation of a novel approach for the use of quantitative galactose-oxidase Schiff reaction in ductal fluid samples from women with breast carcinoma. Cancer 100:2549-2554.
• Evelegh M.J., Marcon N.E., Cox G., Miller J. 2002. A novel method for the quantification of the galactose oxidase Schiff’s reaction and its use in cancer detection. J Clin Ligand Assay 25:91-94
• Zawydiwski R., Sprecher D.L., Evelegh M.J., Horsewood P., Carte C., Patterson M. 2001. A novel test for measurement of skin cholesterol. Clin Chem 47:1302-1304
• Chan, D.W., R. Breveridge, H. Muss, H.A. Fritshce, G. Hortobagyi, R. Theriault, D. Kiang, B.J. Kennedy, and M. Evelegh. 1997. Use of TRUQUANT® BRÔ RIA for early detection of breast cancer recurrence in patients with stage II and stage III disease. J. Clin. Oncol. 15: 2322-2328.